Compounds > panipenem
Page last updated: 2024-08-25

panipenem and ljc 10627

panipenem has been researched along with ljc 10627 in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (53.33)18.2507
2000's7 (46.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jolivette, LJ; Ward, KW1
Lombardo, F; Obach, RS; Waters, NJ1
Distèche-Nguyen, M; Gerards, T; Luxen, A; Miguet, L; Pasha, FA; Thomas, A; Zervosen, A1
Mitsuhashi, S; Yoshida, M1
Hashizume, T; Hazumi, N; Kato, Y; Matsuda, K1
Kanazawa, K; Nouda, H; Sunagawa, M1
Hirata, Y; Igari, J; Imafuku, Y; Inoue, M; Ishigo, S; Kawaguchi, R; Kobayashi, I; Kumasaka, K; Matsuoka, K; Murakami, E; Nishino, T; Oguri, T; Ohtaki, Y; Okada, J; Okamoto, E; Saeki, H; Satou, S; Shibano, T; Takahashi, A; Tokuda, K; Uchida, K; Uehara, N; Watanabe, N; Yomoda, S; Yoshida, H1
Horii, T; Ichiyama, S; Kobayashi, M; Ohta, M1
Hirata, Y; Hongo, T; Igari, J; Imafuku, Y; Inoue, M; Kawaguchi, R; Kobayashi, I; Kobayasi, Y; Kumasaka, K; Matsumoto, N; Nakasaki, N; Nishino, T; Oguri, T; Ohtaki, Y; Okada, J; Saeki, H; Sasaki, T; Satou, S; Shibano, T; Takahashi, A; Tokuda, K; Uehara, N; Watanabe, N; Yomoda, S; Yoshida, H1
Murase, M1
Fujimura, S; Gomi, K; Honda, Y; Kikuchi, T; Kobayashi, T; Nukiwa, T; Shoji, S; Takahashi, H; Tokue, Y; Watanabe, A; Yasui, S1
Aoki, N; Hashimoto, T; Hirata, Y; Hongo, T; Igari, J; Imafuku, Y; Inoue, M; Ishigo, S; Kajimura, K; Kawaguchi, R; Kobayashi, I; Kobayashi, Y; Kumasaka, K; Matsumoto, N; Matsuoka, K; Murakami, E; Nakasaki, N; Nishino, T; Oguri, T; Ohba, Y; Ohtaki, Y; Okada, J; Okamoto, E; Ono, J; Saeki, H; Sasaki, T; Satou, S; Shibano, T; Takahashi, A; Takata, T; Tokuda, K; Uehara, N; Watanabe, N; Yomoda, S; Yoshida, H1
Endo, H; Jinbo, K; Nishinari, C; Suzuki, Y; Tamura, C1
Hikida, M; Inoue, M; Okamoato, R; Sato, Y; Terashima, S1
Araake, M; Gotoh, N; Hiraishi, T; Miyata, A; Nishino, T; Ogawa, H; Takata, T1

Other Studies

15 other study(ies) available for panipenem and ljc 10627

ArticleYear
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
    Journal of pharmaceutical sciences, 2005, Volume: 94, Issue:7

    Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution

2005
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Discovery of new inhibitors of resistant Streptococcus pneumoniae penicillin binding protein (PBP) 2x by structure-based virtual screening.
    Journal of medicinal chemistry, 2009, Oct-08, Volume: 52, Issue:19

    Topics: Computational Biology; Computer Simulation; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Ligands; Penicillin-Binding Proteins; Protein Binding; Streptococcus pneumoniae; Structure-Activity Relationship

2009
In vitro antibacterial activity and beta-lactamase stability of the new carbapenem LJC10,627.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1990, Volume: 9, Issue:8

    Topics: Bacteria; beta-Lactamases; Carbapenems; Cefpirome; Ceftazidime; Cephalosporins; Humans; Imipenem; Molecular Structure; Thienamycins

1990
Effects of a beta-lactamase inhibitor, sulbactam, on the activity of carbapenems against Pseudomonas aeruginosa.
    The Journal of antibiotics, 1995, Volume: 48, Issue:11

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Drug Synergism; Enzyme Inhibitors; Imipenem; Meropenem; Pseudomonas aeruginosa; Sulbactam; Thienamycins

1995
Structure-activity relationships of carbapenem compounds to anti-Haemophilus influenzae activity and affinity for penicillin-binding proteins. Effect of 1 beta-methyl group and C-2 side chain.
    The Journal of antibiotics, 1997, Volume: 50, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Carrier Proteins; Haemophilus influenzae; Hexosyltransferases; Imipenem; Meropenem; Methylation; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Protein Binding; Structure-Activity Relationship; Thienamycins

1997
[Survey of sensitivities of clinical isolates to antibacterial agents (annual report)].
    The Japanese journal of antibiotics, 1997, Volume: 50, Issue:8

    Topics: 4-Quinolones; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Cocci; Haemophilus influenzae; Humans; Imipenem; Meropenem; Monobactams; Penicillins; Pseudomonas aeruginosa; Serratia marcescens; Thienamycins

1997
Relationship between morphological changes and endotoxin release induced by carbapenems in Pseudomonas aeruginosa.
    Journal of medical microbiology, 1999, Volume: 48, Issue:3

    Topics: Carbapenems; Endotoxins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

1999
[Survey of the sensitivities of clinical isolates to antibacterial agents (annual report)].
    The Japanese journal of antibiotics, 1999, Volume: 52, Issue:4

    Topics: Carbapenems; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins; Time Factors

1999
[In vitro antibacterial activities of carbapenems against clinical isolates].
    The Japanese journal of antibiotics, 1999, Volume: 52, Issue:11

    Topics: Bacteria; Enterobacteriaceae; Imipenem; Meropenem; Methicillin Resistance; Pseudomonas aeruginosa; Staphylococcus aureus; Thienamycins

1999
[In vitro activity of biapenem (BIPM) against clinically isolated respiratory pathogens in 1996-1998].
    The Japanese journal of antibiotics, 1999, Volume: 52, Issue:12

    Topics: Bacteria; Carbapenems; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Penicillins; Piperacillin; Respiratory Tract Infections; Thienamycins; Time Factors

1999
[Changes in the antibacterial activity of chemotherapeutic agents (especially carbapenems) for 10 species of clinical isolates between 1994 and 1996. Surveillance group of the sensitivities of clinical isolates to antibacterial agents].
    The Japanese journal of antibiotics, 2000, Volume: 53, Issue:3

    Topics: Bacteria; Carbapenems; Drug Resistance, Microbial; Humans; Imipenem; Japan; Meropenem; Multicenter Studies as Topic; Thienamycins; Time Factors

2000
[Antimicrobial activities of carbapenems and fourth generation cephems against clinically isolated strains].
    The Japanese journal of antibiotics, 2001, Volume: 54, Issue:9

    Topics: Bacteria; Carbapenems; Cefepime; Cefozopran; Cephalosporins; Imipenem; Meropenem; Thienamycins

2001
[Comparative antibacterial activity of carbapenems against P. aeruginosa (1)].
    The Japanese journal of antibiotics, 2001, Volume: 54, Issue:11

    Topics: beta-Lactamases; Carbapenems; Drug Resistance, Microbial; Imipenem; Meropenem; Pseudomonas aeruginosa; Thienamycins

2001
[Bactericidal activity of biapenem against various efflux system mutants of Pseudomonas aeruginosa].
    The Japanese journal of antibiotics, 2002, Volume: 55, Issue:1

    Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Imipenem; Meropenem; Mutation; Pseudomonas aeruginosa; Thienamycins

2002